Roberto Bianco
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 42
- Colorectal Cancer Treatments and Studies 26
- Cancer Treatment and Pharmacology 17
- Cancer Immunotherapy and Biomarkers 11
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 33
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 12
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 17
-
- Monoclonal and Polyclonal Antibodies Research 19
- Co-authors
- Fortunato CiardielloGiampaolo TortoraSabino De PlacidoVincenzo DamianoRosa CaputoA R BiancoG PomaticoGabriella Fontanini
- Journals
- Clinical Cancer Research (14 papers)Insights into Imaging (9 papers)British Journal of Cancer (9 papers)
- Partner nations
- ItalyUnited StatesBrazil
In The Last Decade
Roberto Bianco
193 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 5.0k
- Pulmonary and Respiratory Medicine 3.4k
- Cancer Research 1.2k
- Molecular Biology 3.7k
- Radiology, Nuclear Medicine and Imaging 898
Countries citing papers authored by Roberto Bianco
This map shows the geographic impact of Roberto Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bianco more than expected).
Fields of papers citing papers by Roberto Bianco
This network shows the impact of papers produced by Roberto Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bianco. The network helps show where Roberto Bianco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Bianco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 6 | |
| 10 | 2018 | 9 | |
| 11 | 2018 | 7 | |
| 12 | 2017 | 8 | |
| 13 | 2015 | 97 | |
| 14 | 2014 | 51 | |
| 15 | 2013 | 125 | |
| 16 | 2012 | 91 | |
| 17 | 2011 | 44 | |
| 18 | 2008 | 117 | |
| 19 | Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 2003 | 134 |
| 20 | Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits. | 1996 | 2 |
About Roberto Bianco
Roberto Bianco is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 208 papers that have together received 8.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (42 papers), Lung Cancer Treatments and Mutations (33 papers), Colorectal Cancer Treatments and Studies (26 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), PI3K/AKT/mTOR signaling in cancer (17 papers), Cancer Treatment and Pharmacology (17 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Oncology (5.0k citations), Pulmonary and Respiratory Medicine (3.4k citations), Cancer Research (1.2k citations), Molecular Biology (3.7k citations) and Radiology, Nuclear Medicine and Imaging (898 citations). Roberto Bianco has collaborated with scholars based in Italy, United States and Brazil. Frequent co-authors include Fortunato Ciardiello, Giampaolo Tortora, Sabino De Placido, Vincenzo Damiano, Rosa Caputo, A R Bianco, G Pomatico, Gabriella Fontanini, Roberta Rosa and Carlos L. Arteaga. Their work appears in journals such as Clinical Cancer Research, Insights into Imaging, British Journal of Cancer, Cancers and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.